These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 28525681)

  • 1. Unveiling idiopathic macular telangiectasia: clinical applications of optical coherence tomography angiography.
    Gonzalez MA; Shechtman D; Haynie JM; Semes L
    Eur J Ophthalmol; 2017 Jun; 27(4):e129-e133. PubMed ID: 28525681
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multimodal Imaging of Macular Telangiectasia Type 2: Focus on Vascular Changes Using Optical Coherence Tomography Angiography.
    Toto L; Di Antonio L; Mastropasqua R; Mattei PA; Carpineto P; Borrelli E; Rispoli M; Lumbroso B; Mastropasqua L
    Invest Ophthalmol Vis Sci; 2016 Jul; 57(9):OCT268-76. PubMed ID: 27409482
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optical coherence tomography angiography of macular telangiectasia type 1: Comparison with mild diabetic macular edema.
    Mao L; Weng SS; Gong YY; Yu SQ
    Lasers Surg Med; 2017 Mar; 49(3):225-232. PubMed ID: 28168812
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictive multi-imaging biomarkers relevant for visual acuity in idiopathic macular telangiectasis type 1.
    Guo J; Tang W; Ye X; Wu H; Xu G; Liu W; Zhang Y
    BMC Ophthalmol; 2018 Mar; 18(1):69. PubMed ID: 29506510
    [TBL] [Abstract][Full Text] [Related]  

  • 5. OCT Angiography Helps Distinguish Between Proliferative Macular Telangiectasia Type 2 and Neovascular Age-Related Macular Degeneration.
    Zheng F; Motulsky EH; de Oliveira Dias JR; de López EP; Gregori G; Rosenfeld PJ
    Ophthalmic Surg Lasers Imaging Retina; 2018 May; 49(5):303-312. PubMed ID: 29772040
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ASSOCIATION BETWEEN CHANGES IN MACULAR VASCULATURE IN OPTICAL COHERENCE TOMOGRAPHY- AND FLUORESCEIN- ANGIOGRAPHY AND DISTRIBUTION OF MACULAR PIGMENT IN TYPE 2 IDIOPATHIC MACULAR TELANGIECTASIA.
    Zeimer M; Gutfleisch M; Heimes B; Spital G; Lommatzsch A; Pauleikhoff D
    Retina; 2015 Nov; 35(11):2307-16. PubMed ID: 26465618
    [TBL] [Abstract][Full Text] [Related]  

  • 7. "En face" optical coherence tomography imaging in type 2 idiopathic macular telangiectasia.
    Wolff B; Basdekidou C; Vasseur V; Sahel JA; Gaudric A; Mauget-Faÿsse M
    Retina; 2014 Oct; 34(10):2072-8. PubMed ID: 25255245
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optical Coherence Tomography Angiography of Macular Telangiectasia Type 2.
    Roisman L; Rosenfeld PJ
    Dev Ophthalmol; 2016; 56():146-58. PubMed ID: 27022942
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characteristics and quantification of vascular changes in macular telangiectasia type 2 on optical coherence tomography angiography.
    Chidambara L; Gadde SG; Yadav NK; Jayadev C; Bhanushali D; Appaji AM; Akkali M; Khurana A; Shetty R
    Br J Ophthalmol; 2016 Nov; 100(11):1482-1488. PubMed ID: 26823394
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multimodal imaging in type 2 idiopathic macular telangiectasia.
    Sallo FB; Leung I; Clemons TE; Peto T; Bird AC; Pauleikhoff D
    Retina; 2015 Apr; 35(4):742-9. PubMed ID: 25412037
    [TBL] [Abstract][Full Text] [Related]  

  • 11. OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY VERSUS TRADITIONAL MULTIMODAL IMAGING IN ASSESSING THE ACTIVITY OF EXUDATIVE AGE-RELATED MACULAR DEGENERATION: A New Diagnostic Challenge.
    Coscas GJ; Lupidi M; Coscas F; Cagini C; Souied EH
    Retina; 2015 Nov; 35(11):2219-28. PubMed ID: 26398697
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of OCT Angiography to Diagnose and Manage Atypical Presentations of Macular Telangiectasia Type 2.
    Moir J; Amin SV; Khanna S; Komati R; Shaw LT; Dao D; Hariprasad SM; Skondra D
    Int J Mol Sci; 2022 Jul; 23(14):. PubMed ID: 35887197
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SHORT-TERM FLUCTUATION OF MACULAR EDEMA IN A PATIENT DIAGNOSED EARLY WITH IDIOPATHIC MACULAR TELANGIECTASIA TYPE 1: FOLLOW-UP WITH SPECTRAL DOMAIN OPTICAL COHERENCE TOMOGRAPHY.
    Tsaousis KT; Empeslidis T
    Retin Cases Brief Rep; 2016; 10(3):263-6. PubMed ID: 26584327
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optical Coherence Tomography Angiography in Monitoring Proliferative Macular Telangiectasia Type 2 Treatment Response.
    Estawro RG; Embabi SN
    Ophthalmic Surg Lasers Imaging Retina; 2019 Aug; 50(8):485-491. PubMed ID: 31415694
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optical Coherence Tomography Angiography in Children with Leber-Coats Disease.
    Fortunato M; Turtoro A; Cennamo G
    Ophthalmic Res; 2017; 58(3):185-187. PubMed ID: 28803250
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Visualization of microaneurysms using optical coherence tomography angiography: comparison of OCTA en face, OCT B-scan, OCT en face, FA, and IA images.
    Hamada M; Ohkoshi K; Inagaki K; Ebihara N; Murakami A
    Jpn J Ophthalmol; 2018 Mar; 62(2):168-175. PubMed ID: 29383540
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Select Features of Diabetic Retinopathy on Swept-Source Optical Coherence Tomographic Angiography Compared With Fluorescein Angiography and Normal Eyes.
    Salz DA; de Carlo TE; Adhi M; Moult E; Choi W; Baumal CR; Witkin AJ; Duker JS; Fujimoto JG; Waheed NK
    JAMA Ophthalmol; 2016 Jun; 134(6):644-50. PubMed ID: 27055248
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Swept-Source Optical Coherence Tomography Angiography of Paediatric Macular Diseases.
    Stanga PE; Papayannis A; Tsamis E; Chwiejczak K; Stringa F; Jalil A; Cole T; Biswas S
    Dev Ophthalmol; 2016; 56():166-73. PubMed ID: 27023179
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multimodality imaging in macular telangiectasia 2: A clue to its pathogenesis.
    Wu L
    Indian J Ophthalmol; 2015 May; 63(5):394-8. PubMed ID: 26139799
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fluorescein Angiography Versus Optical Coherence Tomography Angiography in Macular Telangiectasia Type I Treated With Bevacizumab Therapy.
    Yannuzzi NA; Gregori NZ; Roisman L; Gupta N; Goldhagen BE; Goldhardt R
    Ophthalmic Surg Lasers Imaging Retina; 2017 Mar; 48(3):263-266. PubMed ID: 28297041
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.